Zdrowie i gospodarka · 14/07/2009
FDA Announces Grant Funding for Dual Antiplatelet Therapy Trial
The FDA is seeking a sole source grant application from Harvard Clinical Research Institute to support a dual antiplatelet therapy clinical trial, with grant funds allocated through the Office of Critical Path Programs
Source: Federal Register — Food and Drug AdministrationOpen original release →